Carbios (ALCRB.PA), a biotechnology company, on Friday reported a wider net loss for its fiscal 2025, despite higher revenue.
The larger net loss was mainly impacted by a non-cash provision for impairment of shares held in Carbiolice.
Further, the company outlined strategic priorities for the financial year 2026.
For the fiscal 2025, net loss widened to 34.3 million euros from 23.4 million euros last year
Financial loss reached 10.8 million euros reflecting 1.5 million euros in income from cash investments, down 3.1 million euros on lower rates and less invested cash.
Operating loss narrowed by 7 million euros after Carbios cut operating expenses to 30.7 million euros from 37.5 million euros in the previous year.
The decrease was driven by refocusing on strategic priorities, cost cutting and headcount reductions implemented in 2025, and lower external costs including consultancy fees.
The company's revenue growth to 5.74 million euros came mainly from operating grants, service fees invoiced to subsidiaries Carbiolice and Carbios 54, and rebilling of financing related search costs for the Longlaville industrial project.
CEO Vincent Kamel said, 2025 was marked by a major strategic agreement to deploy the licensing model in Asia, progress securing financing for the Longlaville plant, and execution of a cost refocusing plan.
Looking ahead to fiscal 2026, Carbios outlined strategic priorities which was to resume the Longlaville industrial project pending financing expected to close by third quarter 2026.
Furthermore, the company outlines to deploy PET bio recycling technology in Asia through a first facility licensed with Wankai and plans to secure new license agreements across Europe, North America and South America, and also expects to maintain financial discipline.
On the Paris stock exchange, shares of Carbios were trading at 8.02 euros, down 4.53 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
April 10, 2026 16:21 ET Inflation data from the U.S. was the main data event this week as the conflict in the Middle East continue. The minutes of the latest Fed policy session and the survey data on the services sector also made headlines. In Europe, manufacturing orders data from Germany was in focus. Price data from China drew attention in Asia.